EAM
KZR

Erste Asset Management’s Kezar Life Sciences KZR Stock Holding History

Erste Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,100
Closed -$73.8K – 566
2023
Q2 		$73.8K Hold
3,100
– – ﹤0.01% 524
2023
Q1 		$98K Hold
3,100
– – ﹤0.01% 530
2022
Q4 		$218K Hold
3,100
– – ﹤0.01% 489
2022
Q3 		$267K Hold
3,100
– – 0.01% 478
2022
Q2 		$246K Hold
3,100
– – 0.01% 495
2022
Q1 		$524K Buy
+3,100
New +$445K 0.01% 432

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Erste Asset Management's KZR Position: Q3 2023 in Review

Erste Asset Management sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 3,100 shares — an estimated $73.8K sold.

Erste Asset Management first reported a position in KZR in Q1 2022 and held it in 6 quarters. The position peaked at $524K in Q1 2022. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

  • Erste Asset Management reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Erste Asset Management sold 3,100 Kezar Life Sciences shares in Q3 2023, an estimated $73.8K.
  • Erste Asset Management first reported a position in Kezar Life Sciences in Q1 2022 and held it in 6 quarters.
  • Erste Asset Management's Kezar Life Sciences position peaked at $524K in Q1 2022.
  • 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.